🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaolei Wang

Lanzhou University

ORCID: 0000-0001-5441-0855

ChemistryBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway”.

KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway

Frontiers in Oncology(2022)10.3389/fonc.2022.976292

N/A

0DataRank · unranked

6 citations

Yingchun Liu, Xiaolin Su, Jiangwei Wang, Ye Zhao, Soumya Tumbath +9 more

CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer

iScience(2024)10.1016/j.isci.2024.109978

N/A

0DataRank · unranked

12 citations

Sarah B. Gitto, Gwo‐Yaw Ho, Sergey Medvedev, Kristy Shield‐Artin, Hyoung Kim +15 more

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

Research Square(2024)10.21203/rs.3.rs-3854682/v1

N/A

0DataRank · unranked

3 citations

Haineng Xu, Erin Geroge, David Gallo, Sergey Medvedev, Xiaolei Wang +13 more

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

Nature Communications(2025)10.1038/s41467-025-58183-w

N/A

0DataRank · unranked

23 citations

Erin George, David Gallo, Sergey Medvedev, Xiaolei Wang, Arindam Datta +15 more